{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:35:29Z","timestamp":1790645729337,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Mettapracharak(Wat Raikhing)Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s40123-024-01081-z","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:18:43Z","timestamp":1734535123000},"page":"351-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Randomized Clinical Trial of Intraocular Pressure-Lowering Medications on Preventing Spikes in Intraocular Pressure Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections"],"prefix":"10.1007","volume":"14","clinical-trial-number":[{"clinical-trial-number":"tctr20241005001","registry":"10.18810\/tctr"}],"author":[{"given":"Piriya","family":"Soomsawasdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5459-5562","authenticated-orcid":false,"given":"Kulawan","family":"Rojananuangnit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eakkachai","family":"Arayangkoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratchada","family":"Chantiwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sureeporn","family":"Pengrungreungwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nontakorn","family":"Preawsampran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natnaree","family":"Tinpowong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujira","family":"Samakhararaksakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokwan","family":"Katkingkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthapuch","family":"Seekhum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwisa","family":"Sathim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"1","key":"1081_CR1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12886-020-01554-2","volume":"20","author":"RP Finger","year":"2020","unstructured":"Finger RP, Daien V, Eldem BM, et al. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration\u2014a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC Ophthalmol. 2020;20(1):294. https:\/\/doi.org\/10.1186\/s12886-020-01554-2.","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"1081_CR2","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2174\/1574887115666200519073704","volume":"15","author":"AG Elnahry","year":"2020","unstructured":"Elnahry AG, Abdel-Kader AA, Habib AE, Elnahry GA, Raafat KA, Elrakhawy K. Review on recent trials evaluating the effect of intravitreal injections of anti-VEGF agents on the macular perfusion of diabetic patients with diabetic macular edema. Rev Recent Clin Trials. 2020;15(3):188\u201398. https:\/\/doi.org\/10.2174\/1574887115666200519073704.","journal-title":"Rev Recent Clin Trials"},{"issue":"6","key":"1081_CR3","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41433-021-01620-z","volume":"36","author":"KL Spooner","year":"2022","unstructured":"Spooner KL, Fraser-Bell S, Hong T, Wong JG, Chang AA. Long-term outcomes of anti-VEGF treatment of retinal vein occlusion. Eye (Lond). 2022;36(6):1194\u2013201. https:\/\/doi.org\/10.1038\/s41433-021-01620-z.","journal-title":"Eye (Lond)"},{"issue":"6","key":"1081_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3129\/i07-172","volume":"42","author":"H Hollands","year":"2007","unstructured":"Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol. 2007;42(6):807\u201311. https:\/\/doi.org\/10.3129\/i07-172.","journal-title":"Can J Ophthalmol"},{"issue":"10","key":"1081_CR5","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/eye.2014.180","volume":"28","author":"CD Murray","year":"2014","unstructured":"Murray CD, Wood D, Allgar V, Walters G, Gale RP. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients. Eye (Lond). 2014;28(10):1218\u201322. https:\/\/doi.org\/10.1038\/eye.2014.180.","journal-title":"Eye (Lond)"},{"issue":"9","key":"1081_CR6","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00417-017-3702-1","volume":"255","author":"M Soheilian","year":"2017","unstructured":"Soheilian M, Karimi S, Montahae T, Nikkhah H, Mosavi SA. Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: a prospective study. Graefes Arch Clin Exp Ophthalmol. 2017;255(9):1705\u201312. https:\/\/doi.org\/10.1007\/s00417-017-3702-1.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"1081_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/s-0029-1245201","volume":"227","author":"PE Theoulakis","year":"2010","unstructured":"Theoulakis PE, Lepidas J, Petropoulos IK, Livieratou A, Brinkmann CK, Katsimpris JM. Effect of brimonidine\/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab. Klin Monbl Augenheilkd. 2010;227(4):280\u20134. https:\/\/doi.org\/10.1055\/s-0029-1245201.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"10","key":"1081_CR8","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1136\/bjophthalmol-2018-312603","volume":"103","author":"T Felfeli","year":"2019","unstructured":"Felfeli T, Hostovsky A, Trussart R, Yan P, Brent MH, Mandelcorn ED. Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial. Br J Ophthalmol. 2019;103(10):1388\u201394. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312603.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"1081_CR9","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1007\/s10792-021-01885-z","volume":"41","author":"M Dettoraki","year":"2021","unstructured":"Dettoraki M, Rapti E, Fragkos D, et al. Prophylactic effect of brinzolamide-brimonidine fixed combination on intraocular pressure spikes after intravitreal anti-VEGF injections. Int Ophthalmol. 2021;41(9):3191\u20138. https:\/\/doi.org\/10.1007\/s10792-021-01885-z.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"1081_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10792-020-01667-z","volume":"41","author":"N Shoeibi","year":"2021","unstructured":"Shoeibi N, Ghosi Z, Jafari H, Omidtabrizi A. Effect of antiglaucoma agents on short-term intraocular pressure fluctuations after intravitreal bevacizumab injections. Int Ophthalmol. 2021;41(3):1081\u201390. https:\/\/doi.org\/10.1007\/s10792-020-01667-z.","journal-title":"Int Ophthalmol"},{"issue":"12","key":"1081_CR11","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1001\/archophthalmol.2010.297","volume":"128","author":"MPC Frenkel","year":"2010","unstructured":"Frenkel MPC, Haji SA, Frenkel REP. Effect of prophylactic intraocular pressure\u2013lowering medication on intraocular pressure spikes after intravitreal injections. Arch Ophthalmol. 2010;128(12):1523\u20137. https:\/\/doi.org\/10.1001\/archophthalmol.2010.297.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"1081_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/IJG.0b013e31819c4893","volume":"18","author":"M Gismondi","year":"2009","unstructured":"Gismondi M, Salati C, Salvetat ML, Zeppieri M, Brusini P. Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure. J Glaucoma. 2009;18(9):658\u201361. https:\/\/doi.org\/10.1097\/IJG.0b013e31819c4893.","journal-title":"J Glaucoma"},{"issue":"1","key":"1081_CR13","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1038\/s41598-020-70269-7","volume":"10","author":"VA de Vries","year":"2020","unstructured":"de Vries VA, Bassil FL, Ramdas WD. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis. Sci Rep. 2020;10(1):13248. https:\/\/doi.org\/10.1038\/s41598-020-70269-7.","journal-title":"Sci Rep"},{"issue":"12","key":"1081_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/ijg.0000000000001894","volume":"30","author":"AM Levin","year":"2021","unstructured":"Levin AM, Chaya CJ, Kahook MY, Wirostko BM. Intraocular pressure elevation following intravitreal anti-VEGF injections: short- and long-term considerations. J Glaucoma. 2021;30(12):1019\u201326. https:\/\/doi.org\/10.1097\/ijg.0000000000001894.","journal-title":"J Glaucoma"},{"issue":"4","key":"1081_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000486145","volume":"239","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski A, Told R, Sacu S, et al. 2018 Update on intravitreal injections: euretina expert consensus recommendations. Ophthalmologica. 2018;239(4):181\u201393. https:\/\/doi.org\/10.1159\/000486145.","journal-title":"Ophthalmologica"},{"issue":"5","key":"1081_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/24741264211028441","volume":"5","author":"LA Lam","year":"2021","unstructured":"Lam LA, Mehta S, Lad EM, Emerson GG, Jumper JM, Awh CC. Intravitreal injection therapy: current techniques and supplemental services. J Vitreoretin Dis. 2021;5(5):438\u201347. https:\/\/doi.org\/10.1177\/24741264211028441.","journal-title":"J Vitreoretin Dis"},{"issue":"3","key":"1081_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.survophthal.2022.12.002","volume":"68","author":"P Arjmand","year":"2023","unstructured":"Arjmand P, Yu CW, Popovic MM, Jhaveri A, Mandelcorn ED. Prophylactic intraocular pressure lowering measures in anti-vascular endothelial growth factor therapy: a systematic review and meta-analysis. Surv Ophthalmol. 2023;68(3):425\u201345. https:\/\/doi.org\/10.1016\/j.survophthal.2022.12.002.","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"1081_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/tvst.9.9.10","volume":"9","author":"K Kitsu","year":"2020","unstructured":"Kitsu K, Shinoda K, Mizuno Y, et al. Effect of paracentesis on retinal function associated with changes in intraocular pressure caused by intravitreal injections. Transl Vis Sci Technol. 2020;9(9):10. https:\/\/doi.org\/10.1167\/tvst.9.9.10.","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"1081_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/icb.0000000000000939","volume":"16","author":"AP Shah","year":"2022","unstructured":"Shah AP, Sisk RA, Foster RE. Complications of serial anterior chamber paracentesis for increased intraocular pressure after intravitreal injections. Retin Cases Brief Rep. 2022;16(2):136\u201340. https:\/\/doi.org\/10.1097\/icb.0000000000000939.","journal-title":"Retin Cases Brief Rep"},{"key":"1081_CR20","first-page":"1","volume":"4","author":"EJ Higginbotham","year":"2010","unstructured":"Higginbotham EJ. Considerations in glaucoma therapy: fixed combinations versus their component medications. Clin Ophthalmol. 2010;4:1\u20139.","journal-title":"Clin Ophthalmol"},{"key":"1081_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.749858","volume":"12","author":"T Wang","year":"2021","unstructured":"Wang T, Cao L, Jiang Q, Zhang T. Topical medication therapy for glaucoma and ocular hypertension. Front Pharmacol. 2021;12: 749858. https:\/\/doi.org\/10.3389\/fphar.2021.749858.","journal-title":"Front Pharmacol"},{"issue":"17","key":"1081_CR22","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2147\/OPTH.S4142112","volume":"13","author":"SA LoBue","year":"2023","unstructured":"LoBue SA, Gindina S, Saba NJ, Chang T, et al. Clinical features associated with acute elevated intraocular pressure after intravitreal anti-VEGF injections. Clin Ophthalmol. 2023;13(17):1683\u201390. https:\/\/doi.org\/10.2147\/OPTH.S4142112.","journal-title":"Clin Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-01081-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T15:37:54Z","timestamp":1737560274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-01081-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-01081-z","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Piriya Soomsawasdi, Kulawan Rojananuangnit, Eakkachai Arayangkoon, Ratchada Chantiwas, Sureeporn Pengrungreungwong, Nontakorn Preawsampran, Natnaree Tinpowong, Rujira Samakhararaksakul, Kanokwan Katkingkaew, Natthapuch Seekhum, and Wanwisa Sathim declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This randomized double-blind clinical trial was approved by the Mettapracharak (Wat Rai Khing) Research Ethics Committee in accordance with the International Conference on Harmonization Good Clinical Practice (ICH-GCP) COA No 015\/2563. The study was performed in accordance with the Helsinki Declaration of 1964. All participants provided informed consent to participate in the study. All privacy data including hospital number, name, and date of birth were masked and kept confidential.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}